Nemysis Limited | Finanzwire

Basculer en Français

10443	Companies
219223	Keywords
148681	Articles
115959	Press releases

Home
Companies
Nemysis Limited

BRIEF

published on 05/23/2024 at 10:05, 1 year 11 months ago

Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement

Nutritional Supplement IHAT Patent Iron Deficiency Nemysis Limited
PRESS RELEASE

published on 05/23/2024 at 10:00, 1 year 11 months ago

Nemysis Limited Announces the Grant of Further IP for its IHAT Oral Iron Supplement
Nemysis strengthens IP portfolio with new patent (WO2021204705) for IHAT oral iron supplement, safe for iron deficiency treatment. Dr. Comelli and Dr. Faria comment on significance

IHAT Patent IP Portfolio Iron Deficiency Nemysis
PRESS RELEASE

published on 01/10/2024 at 17:00, 2 years 4 months ago

Nemysis Limited Signs With Kolinpharma SpA an IHAT Sales and Marketing Agreement
Nemysis Ltd and Kolinpharma® SpA have signed a non-exclusive sales and marketing agreement for IHAT (Iron Hydroxide Adipate Tartrate), Nemysis' innovative oral iron supplementation product. This partnership aims to enhance coverage of the target markets within Italy, one of the largest in Europe, and improve access to effective iron deficiency solutions.

Nemysis Ltd Kolinpharma® SpA IHAT Iron Supplementation Italy Market

Accesswire

Published on 05/23/2026 at 00:15, 39 minutes ago

Molten Metals Completes Airborne Geophysical Survey at Texas Project
Published on 05/23/2026 at 00:00, 54 minutes ago

Redwood AI Announces Collaboration with Resilience Biosciences Inc. to Advance AI-Assisted Small-Molecule Drug Development
Published on 05/22/2026 at 23:01, 1 hour 53 minutes ago

Water Ways Announces Corporate Updates
Published on 05/22/2026 at 18:40, 6 hours 14 minutes ago

Vertical Announces Grant of Options
Published on 05/22/2026 at 14:04, 10 hours 50 minutes ago

Wi2Wi Corporation Announces First Quarter 2026 Financial Results (Unaudited)

View all ACCESSWIRE

EQS Group

Published on 05/22/2026 at 22:05, 2 hours 49 minutes ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 5 hours 3 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices
Published on 05/22/2026 at 18:33, 6 hours 21 minutes ago

Update on Coupon payment due on 23 May 2026 and Preparation of the Green Bond Restructuring
Published on 05/22/2026 at 18:30, 6 hours 24 minutes ago

Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/22/2026 at 18:29, 6 hours 25 minutes ago

Designated Person Notification

Les Echos

Published on 05/22/2026 at 18:05, 6 hours 49 minutes ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 12 hours 1 minute ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026
Published on 05/22/2026 at 08:30, 16 hours 24 minutes ago

Eiffage is building four solar power plants for the NOOR Atlas programme in Morocco
Published on 05/21/2026 at 17:50, 1 day 7 hours ago

CDA - H1 results 2025 2026
Published on 05/21/2026 at 17:45, 1 day 7 hours ago

CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

View all LES ECHOS COMFI WIRE